Fund HoldingsCAXTON CORP

Total Portfolio Value
$17.55M
Total Bought
$1.05M
Total Sold
$4.13M
Net Transaction
-$3.08M
Filing Period:
Securities
SharesValue ($K)
Q4 2023
Q1 2024
Change
Q4 2023
Q1 2024
Weight (%)
Change
REZOLUTE INC1,318,9671,318,96701,3093,36319.16%+2,054
KYVERNA THERAPEUTICS INC015,846+15,84603942.24%+394
SPDR S&P 500 ETF TR(SPY)1,3221,856+5346289715.53%+343
MIND MEDICINE MINDMED INC029,065+29,06502731.56%+273
BERKSHIRE HATHAWAY INC DEL1,0351,019-163694282.44%+59
ABIVAX SA(ABVX)16,74315,808-9351792261.29%+47
ADICET BIO INC017,488+17,4880410.23%+41
LEXEO THERAPEUTICS INC10,31910,31901381620.92%+23
COMPASS THERAPEUTICS INC43,46543,465068860.49%+18
ALLAKOS INC24,7100-24,710670-67
HARPOON THERAPEUTICS INC13,1760-13,1761290-129
MOLECULAR TEMPLATES INC136,866136,86605113071.75%-204
APOGEE THERAPEUTICS INC(APGE)7,3530-7,3532050-205
SAVARA INC(SVRA)353,4410-353,4411,6610-1,661
XERIS BIOPHARMA HOLDINGS INC5,641,9205,113,348-528,57213,25911,30064.38%-1,958
Page 1 of 1